Record Information |
---|
Version | 5.0 |
---|
Status | Expected but not Quantified |
---|
Creation Date | 2012-09-06 15:16:52 UTC |
---|
Update Date | 2022-03-07 02:51:59 UTC |
---|
HMDB ID | HMDB0015444 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | Hexobarbital |
---|
Description | Hexobarbital is only found in individuals that have used or taken this drug. It is a barbiturate that is effective as a hypnotic and sedative. [PubChem]Hexobarbital binds at a distinct binding site associated with a Cl- ionopore at the GABA-A receptor, increasing the duration of time for which the Cl- ionopore is open. The post-synaptic inhibitory effect of GABA in the thalamus is, therefore, prolonged. |
---|
Structure | CN1C(=O)NC(=O)C(C)(C1=O)C1=CCCCC1 InChI=1S/C12H16N2O3/c1-12(8-6-4-3-5-7-8)9(15)13-11(17)14(2)10(12)16/h6H,3-5,7H2,1-2H3,(H,13,15,17) |
---|
Synonyms | Value | Source |
---|
5-(1-Cyclohexen-1-yl)-1,5-dimethyl-2,4,6(1H,3H,5H)-pyrimidinetrione | ChEBI | 5-(1-Cyclohexen-1-yl)-1,5-dimethylbarbituric acid | ChEBI | 5-Cyclohex-1-enyl-1,5-dimethyl-pyrimidine-2,4,6-trione | ChEBI | Evipan | ChEBI | Hexobarbitone | ChEBI | Methexenyl | ChEBI | Methylhexabital | ChEBI | 5-(1-Cyclohexen-1-yl)-1,5-dimethylbarbitate | Generator | 5-(1-Cyclohexen-1-yl)-1,5-dimethylbarbitic acid | Generator | Hexenal | MeSH, HMDB | Hexobarbital, sodium | MeSH, HMDB | Sodium hexobarbital | MeSH, HMDB |
|
---|
Chemical Formula | C12H16N2O3 |
---|
Average Molecular Weight | 236.267 |
---|
Monoisotopic Molecular Weight | 236.116092388 |
---|
IUPAC Name | 5-(cyclohex-1-en-1-yl)-1,5-dimethyl-1,3-diazinane-2,4,6-trione |
---|
Traditional Name | hexobarbital |
---|
CAS Registry Number | 56-29-1 |
---|
SMILES | CN1C(=O)NC(=O)C(C)(C1=O)C1=CCCCC1 |
---|
InChI Identifier | InChI=1S/C12H16N2O3/c1-12(8-6-4-3-5-7-8)9(15)13-11(17)14(2)10(12)16/h6H,3-5,7H2,1-2H3,(H,13,15,17) |
---|
InChI Key | UYXAWHWODHRRMR-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as pyrimidones. Pyrimidones are compounds that contain a pyrimidine ring, which bears a ketone. Pyrimidine is a 6-membered ring consisting of four carbon atoms and two nitrogen centers at the 1- and 3- ring positions. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organoheterocyclic compounds |
---|
Class | Diazines |
---|
Sub Class | Pyrimidines and pyrimidine derivatives |
---|
Direct Parent | Pyrimidones |
---|
Alternative Parents | |
---|
Substituents | - Pyrimidone
- Hydropyrimidine
- 1,2,5,6-tetrahydropyrimidine
- Dicarboximide
- Carbonic acid derivative
- Azacycle
- Organic 1,3-dipolar compound
- Propargyl-type 1,3-dipolar organic compound
- Carboxylic acid derivative
- Organic oxide
- Hydrocarbon derivative
- Organic nitrogen compound
- Organooxygen compound
- Organonitrogen compound
- Carbonyl group
- Organopnictogen compound
- Organic oxygen compound
- Aliphatic heteromonocyclic compound
|
---|
Molecular Framework | Aliphatic heteromonocyclic compounds |
---|
External Descriptors | |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | |
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | | Show more...
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
Hexobarbital,1TMS,isomer #1 | CN1C(=O)N([Si](C)(C)C)C(=O)C(C)(C2=CCCCC2)C1=O | 1956.3 | Semi standard non polar | 33892256 | Hexobarbital,1TMS,isomer #1 | CN1C(=O)N([Si](C)(C)C)C(=O)C(C)(C2=CCCCC2)C1=O | 1948.2 | Standard non polar | 33892256 | Hexobarbital,1TMS,isomer #1 | CN1C(=O)N([Si](C)(C)C)C(=O)C(C)(C2=CCCCC2)C1=O | 2611.4 | Standard polar | 33892256 | Hexobarbital,1TBDMS,isomer #1 | CN1C(=O)N([Si](C)(C)C(C)(C)C)C(=O)C(C)(C2=CCCCC2)C1=O | 2179.9 | Semi standard non polar | 33892256 | Hexobarbital,1TBDMS,isomer #1 | CN1C(=O)N([Si](C)(C)C(C)(C)C)C(=O)C(C)(C2=CCCCC2)C1=O | 2194.4 | Standard non polar | 33892256 | Hexobarbital,1TBDMS,isomer #1 | CN1C(=O)N([Si](C)(C)C(C)(C)C)C(=O)C(C)(C2=CCCCC2)C1=O | 2736.7 | Standard polar | 33892256 |
| Show more...
---|
Spectra |
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Experimental GC-MS | GC-MS Spectrum - Hexobarbital EI-B (Non-derivatized) | splash10-00gi-9420000000-001b8f1462933b4fb9c1 | 2017-09-12 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - Hexobarbital EI-B (Non-derivatized) | splash10-00gi-9420000000-001b8f1462933b4fb9c1 | 2018-05-18 | HMDB team, MONA, MassBank | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Hexobarbital GC-MS (Non-derivatized) - 70eV, Positive | splash10-004i-3940000000-827e61b1deec4916f579 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Hexobarbital GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Hexobarbital GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | MS | Mass Spectrum (Electron Ionization) | splash10-05cu-9310000000-eeec363075c613d35696 | 2014-09-20 | Not Available | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Hexobarbital 10V, Positive-QTOF | splash10-000i-1190000000-58f9b3cb0025cd8911aa | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Hexobarbital 20V, Positive-QTOF | splash10-014i-2920000000-e4d6ce12b6d33fff56d8 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Hexobarbital 40V, Positive-QTOF | splash10-0uxu-9100000000-55244be11c0d8667c413 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Hexobarbital 10V, Negative-QTOF | splash10-000f-7980000000-db4b09996693417c3e09 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Hexobarbital 20V, Negative-QTOF | splash10-0bt9-5900000000-3fac68a4cc2e19e26087 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Hexobarbital 40V, Negative-QTOF | splash10-0006-9200000000-8495751984d2901a8826 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Hexobarbital 10V, Positive-QTOF | splash10-000i-0390000000-d08c51477abaf85bbfa5 | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Hexobarbital 20V, Positive-QTOF | splash10-0a4i-1930000000-cc97a14668452a4e91e1 | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Hexobarbital 40V, Positive-QTOF | splash10-0a4i-6900000000-3951ea29d6dcc2dca21b | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Hexobarbital 10V, Negative-QTOF | splash10-000i-3490000000-509890f29192f5ebf006 | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Hexobarbital 20V, Negative-QTOF | splash10-0a4l-5970000000-fb452294b839815fbe4b | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Hexobarbital 40V, Negative-QTOF | splash10-000x-9450000000-ae3101e9d97123ad0a93 | 2021-10-11 | Wishart Lab | View Spectrum |
NMR SpectraSpectrum Type | Description | Deposition Date | Source | View |
---|
| Show more...
---|
Biological Properties |
---|
Cellular Locations | |
---|
Biospecimen Locations | |
---|
Tissue Locations | Not Available |
---|
Pathways | |
---|
Normal Concentrations |
---|
| |
Blood | Expected but not Quantified | Not Quantified | Not Available | Not Available | Taking drug identified by DrugBank entry DB01355 | | details | Urine | Expected but not Quantified | Not Quantified | Not Available | Not Available | Taking drug identified by DrugBank entry DB01355 | | details |
|
---|
Abnormal Concentrations |
---|
| Not Available |
---|
Predicted Concentrations |
---|
| |
Blood | 0.000 uM | Adult (>18 years old) | Both | Normal | Predicted based on drug qualities | Blood | 0.000 umol/mmol creatinine | Adult (>18 years old) | Both | Normal | Predicted based on drug qualities |
|
---|
Associated Disorders and Diseases |
---|
Disease References | None |
---|
Associated OMIM IDs | None |
---|
External Links |
---|
DrugBank ID | Not Available |
---|
Phenol Explorer Compound ID | Not Available |
---|
FooDB ID | Not Available |
---|
KNApSAcK ID | C00016768 |
---|
Chemspider ID | 3482 |
---|
KEGG Compound ID | C11723 |
---|
BioCyc ID | Not Available |
---|
BiGG ID | Not Available |
---|
Wikipedia Link | Hexobarbital |
---|
METLIN ID | Not Available |
---|
PubChem Compound | Not Available |
---|
PDB ID | Not Available |
---|
ChEBI ID | 5706 |
---|
Food Biomarker Ontology | Not Available |
---|
VMH ID | Not Available |
---|
MarkerDB ID | Not Available |
---|
Good Scents ID | rw1399301 |
---|
References |
---|
Synthesis Reference | Not Available |
---|
Material Safety Data Sheet (MSDS) | Not Available |
---|
General References | - Korkmaz S, Ljungblad E, Wahlstrom G: Interaction between flumazenil and the anesthetic effects of hexobarbital in the rat. Brain Res. 1995 Apr 10;676(2):371-7. [PubMed:7614008 ]
- Dall V, Orntoft U, Schmidt A, Nordholm L: Interaction of the competitive AMPA receptor antagonist NBQX with hexobarbital. Pharmacol Biochem Behav. 1993 Sep;46(1):73-6. [PubMed:8255925 ]
- Wahlstrom G: A study of the duration of acute tolerance induced with hexobarbital in male rats. Pharmacol Biochem Behav. 1998 Apr;59(4):945-8. [PubMed:9586853 ]
- Takenoshita R, Toki S: [New aspects of hexobarbital metabolism: stereoselective metabolism, new metabolic pathway via GSH conjugation, and 3-hydroxyhexobarbital dehydrogenases]. Yakugaku Zasshi. 2004 Dec;124(12):857-71. [PubMed:15577260 ]
|
---|